Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study

This multicenter, phase 4, Prospective Randomized Open, Blinded End‐point (PROBE) study aimed to evaluate safety and efficacy of telmisartan/rosuvastatin single‐pill combination (SPC) therapy on lowering central blood pressure (BP) compared with telmisartan monotherapy in hypertensive patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, JungMin, Sung, Ki‐Chul, Ihm, Sang‐Hyun, Yoon, Chang‐Hwan, Park, Seung Woo, Park, Sung‐Ha, Kim, Jang‐Young, Kwon, Sung‐Uk, Lee, Hae‐Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678791/
https://www.ncbi.nlm.nih.gov/pubmed/34384001
http://dx.doi.org/10.1111/jch.14345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678791/
https://www.ncbi.nlm.nih.gov/pubmed/34384001
http://dx.doi.org/10.1111/jch.14345

Ejemplares similares